Skip to content
Screener

Revolution Medicines, Inc. RVMD Other Non-Current Assets

Other Non-Current Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$6.38B+7.4%
Eli Lilly logo
Eli LillyLLY
$7.48B+20.2%
Amgen logo
AmgenAMGN
$12.98B+17.7%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$18.62M+12.1%
Erasca, Inc. logo
Erasca, Inc.ERAS
$1.45M-44.7%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$156K-11.4%

Other financials

Income statement

See full
Revenue-
Operating income-$505.1M-90.8%
Net income-$644.4M-160%
EPS (diluted)-$3.06-134%

Balance sheet

See full
Cash & equivalents$815.4M+103%
Total debt$154.5M+16.3%
Total equity$2.6B+39.7%
Total assets$4.3B+77.9%

Cash flow

See full
Operating cash flow-$387.3M-74.7%
CapEx$2.3M-69.3%
Free cash flow-$389.6M-70.0%

Valuation

See full
Market cap$41.95B+514%
Enterprise value$41.28B+529%

Profitability

See full
Operating margin-88,031.9%-89,488pp
Net margin-76,423.3%-77,733pp
FCF margin-74,273.9%-75,457pp

Returns & leverage

See full
Return on equity-79.1%+182pp
Debt / equity0.1×0.0×
Current ratio11.4×-0.4×

Where this comes from

Reported directly by Revolution Medicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Revolution Medicines, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:10 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335104
Line itemJune 30, 2026December 31, 2025
Goodwill14,60814,608
Restricted cash4,8584,858
Long-term deposits42,45424,148
Other noncurrent assets14,76014,779
Total assets$4,323,270$2,354,508
Liabilities and stockholdersʼ equity
Current liabilities:
Accounts payable$88,419$64,616

Item 1. Financial Statements.

FAQ

What is Revolution Medicines, Inc.'s other non-current assets?
Revolution Medicines, Inc. (RVMD) reported other non-current assets of $14.76M in Q2 2026.
How has Revolution Medicines, Inc.'s other non-current assets changed year-over-year?
Revolution Medicines, Inc.'s other non-current assets decreased by 53.0% year-over-year, from $31.42M to $14.76M.
What is the long-term trend for Revolution Medicines, Inc.'s other non-current assets?
Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s other non-current assets has grown at a 117.3% compound annual growth rate (CAGR), from $305K to $14.78M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about Revolution Medicines, Inc.'s other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude